Condition
Retinoblastoma clinical trials and research
As of November 12, 2026, Find a Trial lists 15 Retinoblastoma clinical trials that are recruiting, at sites in 11 countries (most in United States (7), China (4), Canada (2)). By phase: Phase 3 (2), Early Phase 1 (2), Phase 2/3 (1), Phase 2 (1). The most active sponsors are Sun Yat-sen University (2), Eye & ENT Hospital of Fudan University (2). There are also 13 NIH-funded research projects on Retinoblastoma, with $7.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 13NIH research projects
- 11Countries
Newest Retinoblastoma clinical trials
All recruiting trials (15)
-
High-dose Topotecan treatment for recurrent retinoblastoma with vitreous seeds
This study is testing whether high-dose Topotecan can help patients with recurrent retinoblastoma and vitreous seeds keep their eye while fighting the tumor.
-
Linking RB1 genetic changes to eye tumors and metastasis
We will use targeted long-read genetic sequencing on people with retinoblastoma to see if specific RB1 mutations match tumor features and the risk of spread.
-
Treatment for advanced retinoblastoma using a chemoplaque
This study is testing a new treatment using a special chemotherapy patch for young children with advanced retinoblastoma to see if it helps fight the cancer while keeping their vision safe.
-
New treatment for children with hard-to-treat retinoblastoma
This study is testing a new drug for children with hard-to-treat eye cancer to see if it works better and has fewer side effects than standard chemotherapy.
-
Understanding the incidence and outcomes of trilateral retinoblastoma
This study looks at how common trilateral retinoblastoma is and how well patients survive, comparing data from different countries to see if there are differences based on income levels.
-
Chemotherapy for high-risk retinoblastoma after eye removal
This study is testing if giving chemotherapy after removing the eye can help prevent high-risk retinoblastoma from coming back in children with Stage I disease.
-
Collecting and analyzing eye fluid from children with retinoblastoma
This study is trying to see if collecting eye fluid from children with retinoblastoma can help find important markers for better treatment and understanding of the disease.
-
Using topotecan and melphalan to treat retinoblastoma
This study is testing if giving the chemotherapy drugs topotecan and melphalan directly into the eye can effectively treat retinoblastoma while saving the eye from removal.
-
New treatments for retinoblastoma to improve vision outcomes
This study is testing new treatment options for children with retinoblastoma to see if they can improve vision and control the disease better than current methods.
-
Improving treatment recommendations for children with retinoblastoma in Africa
This study is trying to see if better treatment recommendations and early diagnosis can help improve survival rates for children with retinoblastoma in Africa.
-
Evaluating health outcomes in retinoblastoma patients after treatment
This study looks at the health and vision outcomes of people who have been treated for retinoblastoma to see how they are doing over time.
-
Examining the impact of anesthesia on brain development in children with retinoblastoma
This study is trying to see if having anesthesia for retinoblastoma treatment affects how well children think and develop compared to those who haven't had anesthesia.
-
Using MRI to predict chemotherapy response in children with retinoblastoma
This study is testing whether special MRI scans can help doctors predict how well children with retinoblastoma will respond to chemotherapy.
-
Investigating genetic factors in childhood cancer
This study is trying to find out if certain genes passed down in families can increase the risk of childhood cancer by looking at samples from kids who have had cancer and their relatives.
-
Collecting and storing samples from children and adults with common childhood cancers
This study is collecting and storing samples from children and adults with common childhood cancers to help researchers learn more about these diseases and find better treatments.
NIH-funded research (13)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Understanding how premalignant retinoblastoma lesions form and progress in children
Researchers are studying how early retinal lesions in kids with RB1 loss become malignant, with the goal of finding ways to prevent retinoblastoma progression.
-
Aqueous humor liquid biopsy to guide prognosis and monitoring in children with retinoblastoma
A liquid test using a small amount of eye fluid could reveal important tumor details to help predict how retinoblastoma in young children will behave and how well treatment is working.
-
Parent-of-Origin Effects in Retinoblastoma: Epigenetic Drivers of Tumor Risk and Progression
A study using long-read DNA sequencing to understand how the parent of origin of RB1 gene variants affects retinoblastoma risk and progression, with potential to guide personalized monitoring and treatment.
-
Retinoblastoma eye-sparing treatment for young children
A new, targeted eye treatment for young children with retinoblastoma aims to save eyes and reduce radiation exposure by delivering medicine directly into the eye.
-
How early retinal changes lead to retinoblastoma
This project looks at how early abnormal cells in the retina form and later turn into retinoblastoma in children, using lab-grown retinal tissue.
-
A tiny eye-fluid test to predict and track retinoblastoma in young children
This project uses a very small sample of eye fluid to look for tumor DNA that could help predict how retinoblastoma will behave and to follow treatment in children.
-
Handheld wide-view 3D eye scanner to find tiny retinoblastoma tumors
This project is building a new handheld 3D eye scanner intended to help find very small retinoblastoma tumors early in young children who need screening.
-
New treatment for retinoblastoma in young children
This study is testing a new way to treat retinoblastoma, a rare eye cancer in babies and young kids, by using a special device to deliver a chemotherapy drug right to the eye, which could help keep the cancer away without needing more intense treatments like surgery or radiation.
-
Using eye fluid to improve diagnosis and monitoring of childhood eye cancer.
This study is exploring a new way to check for eye cancer in kids by looking at a special fluid in their eyes, which could help doctors find important genetic clues without needing to do risky surgeries.
-
Creating a 3D model to study childhood eye cancer
This study is working on a new way to grow tiny eye models to learn more about retinoblastoma, the most common eye cancer in kids, so that we can find better and safer treatments for young patients.
-
Understanding how retinoblastoma, a childhood eye cancer, develops using 3D models of retinal cells.
This study is looking at how retinoblastoma, a rare eye cancer in kids, starts and grows by using special lab-created eye tissues from children with genetic changes, which could help find better ways to treat the disease.
-
Understanding how the retinoblastoma protein is controlled in cancer cells
This study is looking at how a protein that helps prevent cancer, called Rb, is controlled in breast cancer, especially for patients who are being treated with specific medications, and it hopes to find better ways to make these treatments work more effectively for those with hormone-receptor positive, HER2-negative me
-
Improving early detection of retinoblastoma in children using advanced imaging technology
This study is testing a new handheld device that takes detailed pictures of the eye to help doctors find early signs of retinoblastoma, a type of eye cancer in kids, so they can catch it sooner and provide better care.
Related topics
Quick answers
How many Retinoblastoma clinical trials are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (7 trials), China (4 trials), Canada (2 trials), France (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Early Phase 1: 2, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.